Prognostic value of heart rate variability in time domain analysis in congestive heart failure

Journal of Interventional Cardiac Electrophysiology

Volumn 5, Issue 2, 2001, Pages 181-187

  Boveda, Serge ^a   Galinier, Michel ^a,b   Pathak, Atul ^a,b   Fourcade, Joëlle ^a   Dongay, Bruno ^a   Benchendikh, Delphine ^a   Massabuau, Pierre ^a   Fauvel, Jean Marie ^a   Senard, Jean Michel ^b   Bounhoure, Jean Paul ^a  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

Author keywords

Heart failure; Heart rate variability; Prognostic value

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RR INTERVAL;

ADULT; AGED; CIRCADIAN RHYTHM; CONFIDENCE INTERVALS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK; STROKE VOLUME; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0035009346     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011485609838     Document Type: Article

References (32)

1. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. JAm Coll Cardiol 1993;22(suppl):6A-13A.
2. Galinier M, Vialette JC, Fourcade J, Cabrol P, Dongay B, Massabuau P, Boveda S, Doazan JP, Fauvel JM, Bounhoure JP. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. Eur Heart J 1998; 19:1054-1062.
3. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovasuclar function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-1736.
4. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(suppl VI):VI-40-48.
5. Hirsch AT, Dzau VJ, Creager MA. Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance. Circulation 1987;75(suppl IV):IV-36-48.
6. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variabilility: Standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043-1065.
7. Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1988;61:1292-1299.
8. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variaibility in congestive heart failure. Am J Cardiol 1989;64:1162-1167.
9. Binkley PF, Nunziata E, Hass GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: Demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991;18:464-472.
10. Kienzle MG, Ferguson DW, Birkett CL, Myers GA, Berg WJ, Mariano J. Clinical, hemodynamical and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol 1992; 69:761-767.
11. Szabo BM, Van Veldhuisen DJ, Brouwer J, Haaksma J, Lie KI. Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995;76:713-716.
12. Binder T, Freys N, Porenta G, Heinz G, Wutte M, Kreiner G, Gossinger H, Schmidinger H, Pacher R, Weber H. Prognostic value of heart rate variability in patients awaiting cardiac transplantation. Pacing Clin Electrophysiol 1992;15:2215-2220.
13. Mortara A, La Rovere MT, Sigorini MG, Pantaleo P, Pinna G, Martinelli L, Ceconi C, Cerutti S, Tavazzi L. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J 1994;71:422-430.
14. Fei L, Keeling PJ, Gill JS, Bashir Y, Statters DJ, Poloniecki J, McKenna WJ, Camm AJ. Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure. Br Heart J 1994;71:322-328.
15. Brouwer J, Van Veldhuisen DJ, Man in't Veld AJ, Haaksman J, Dijk WA, Visser KR, Boomsma F, Dunselman PH, Lie KI, for the Dutch Ibopamine Multicenter Trial Study Group. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. J Am Coll Cardiol 1996;28:1183-1189.
16. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JMM, Fox KAA. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 1998;98:1510-1516.
17. Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabek K, Coats AJ. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:1645-1650.
18. Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy: Characteristics and prognostic value. J Am Coll Cardiol 1997;30:1009-1014.
19. Gibelin P, Dadoun-Dybal M, Morand P. Variabilité de la fréquence cardiaque dans l'insuffisance cardiaque chronique: Influence de la gravité et de l'étiologie. Arch Mal Coeur 1994;87:1207-1211.
20. Nolan J, Flapan AD, Capewell S, MacDonald T, Neilson JMM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 1992;67:482-486.
21. Tanabe T, Iwamoto T, Fusegawa Y, Yoshioka K, Shiina Y. Alterations of sympathovagal balance in patients with hypertrophic and dilated cardiomyopathies assessed by spectral analysis of RR interval variability. Eur Heart J 1995;16:799-807.
22. Szabo BM, Van Veldhuisen DJ, Van der Veer N, Brouwer J, De Graeff PA, Crijus HJ. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic of ischaemic dilated cardiomyopathy. Am J Cardiol 1997;79:978-980.
23. Parati G, Saul JP, Di Rieuzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: A critical appraisal. Hypertension 1995;25:1276-1286.
24. Mortara A, Sleight P, Pinna GD, Maestri R, Prpa A, La Rouvere MT, Cobelli F, Tavazzi L. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation 1997;96:246-252.
25. Bernadi L, Valle F, Coco M, Calciati A, Sleight P. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res 1996;32:234-237.
26. Pousset F, Copie X, Lechart P, Jaillon P, Boissel JP, Hetzel M, Fillette F, Remme W, Guize L, Le Heuzey JY. Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol 1996;77:612-617.
27. Slatton ML, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 1997;29:1206-1213.
28. Adamopoulos S, Ponikowski P, Cerquetani E, Piepoli M, Rosano G, Sleight P, Coats A. Circadian pattern of heart rate variability in chronic heart failure patients: Effects of physical training. Eur Heart J 1995;16:1380-1386.
29. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996 ;334:1349-1355.
30. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997;349:375-380.
31. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.
32. Tuininga YS, Van Veldhuisen DJ, Brouver J, Haaksma J, Crijns HJGM, Man in't Veld AJ, Lie KI. Heart rate variability in left ventricular dysfunction and heart failure: Effects and implications of drug treatment. Br Heart J 1994;72:509-513.